Provided by Tiger Fintech (Singapore) Pte. Ltd.

CervoMed

8.58
+0.16001.90%
Volume:172.79K
Turnover:1.49M
Market Cap:74.67M
PE:-4.00
High:8.99
Open:8.73
Low:8.35
Close:8.42
Loading ...

CervoMed’s Promising Clinical Trial Data and Strategic Focus Boost Buy Rating and Price Target

TIPRANKS
·
29 Jul

CervoMed Shares Jump 45% Premarket After Positive Dementia Drug Trial Data

THOMSON REUTERS
·
28 Jul

BUZZ-CervoMed jumps on dementia drug trial data

Reuters
·
28 Jul

CervoMed Announces 32-Week Data from RewinD-LB Trial Extension Phase Showing Neflamapimod’s Sustained Effect on Slowing Clinical Progression in Patients with Dementia with Lewy Bodies and Associated Reduction in a Key Plasma Biomarker of Neurodegeneration

GlobeNewswire
·
28 Jul

CervoMed Is Maintained at Buy by D. Boral Capital

Dow Jones
·
25 Jul

CervoMed to Present New Data from Phase 2b RewinD-LB Study at AAIC 2025 and Host Conference Call on July 28, 2025

GlobeNewswire
·
25 Jul

CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025

GlobeNewswire
·
08 Jul

CervoMed Stockholders Approve Key Proposals at Annual Meeting

TIPRANKS
·
26 Jun

CervoMed Inc. Conducted Annual Stockholders Meeting

Reuters
·
26 Jun

CervoMed Is Maintained at Buy by D. Boral Capital

Dow Jones
·
11 Jun

CervoMed appoints Marco Verwijs as EVP, technical operations

TIPRANKS
·
10 Jun

CervoMed Inc. Files Initial Statement of Beneficial Ownership for Mark De Rosch, EVP, RA and GA and PgM

Reuters
·
24 May

CervoMed Releases New Business and Financial Information

TIPRANKS
·
20 May

CervoMed Inc. Unveils Presentation on Pioneering Oral Drug Neflamapimod for Dementia with Lewy Bodies

Reuters
·
17 May

CervoMed’s Strategic Advancements and Market Opportunities Drive Buy Rating

TIPRANKS
·
17 May

CervoMed Inc. CFO William Robert Elder Reports Acquisition of Common Shares

Reuters
·
15 May

Chardan Adjusts Price Target on CervoMed to $15 From $14, Maintains Buy Rating

MT Newswires Live
·
13 May

Analysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Biohaven Ltd. (BHVN)

TIPRANKS
·
13 May

CervoMed (CRVO) Receives a Buy from Roth MKM

TIPRANKS
·
13 May

CervoMed Inc. Reports Q1 2025 Financial Results

TIPRANKS
·
13 May